Anti-Integrin αvβ6 ADCC Enhanced Antibody (264RAD) is an ADCC enhanced antibody produced by our Afuco™ platform. 264RAD is a human therapeutic antibody, which binds and inhibits αvβ6 integrin function. 264RAD cross-reacts with human, mouse and cynomolgus monkey αvβ6, and inhibits binding to all ligands including the latency-associated peptide of TGF-β. 264RAD is a potent inhibitor of αvβ6 integrin, with some activity against αvβ8 integrin, that reduces both tumour growth and metastasis.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-449CL | Human Anti-Integrin αvβ6 Recombinant Antibody (TAB-449CL) | Inhib, FuncS | Human IgG |
TAB-763LC | Anti-human Integrin αvβ6 Recombinant Antibody (TAB-763LC) | Cyt, FuncS, Inhib | Human antibody |
TAB-764LC | Anti-human Integrin αvβ6 Recombinant Antibody (TAB-764LC) | Cyt, FuncS, Inhib | Human antibody |
TAB-765LC | Anti-human Integrin αvβ6 Recombinant Antibody (TAB-765LC) | Cyt, FuncS, Inhib | Human antibody |
TAB-763LC-S(P) | Anti-human Integrin αvβ6 scFv Fragment (TAB-763LC-S(P)) | ELISA | Human antibody |
There are currently no Customer reviews or questions for AFC-431CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.